日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Targeting PD-1 and CD85j can restore intratumoral CD4(+) GzmB(+) T-cell functions to combat MHC-II-expressing tumors

靶向PD-1和CD85j可以恢复肿瘤内CD4(+)GzmB(+)T细胞的功能，从而对抗表达MHC-II的肿瘤。

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2024-010890
Wang, Boyu; Wang, Xu; Wang, Tianlai; Meng, Kelin; Yu, Taiyan; Xi, Yu; Hu, Shaojie; Xiong, Hui; Qu, Rirong; Yuan, Zhiwei; Wang, Xue; Zeng, Chenxi; Zou, Wenbin; Tian, Yitao; Cai, Yixin; Fu, Shengling; Fu, Xiangning; Li, Lequn
肿瘤
T细胞
肿瘤免疫
PD-1
CD8
T细胞
细胞生物学
CD4
免疫/内分泌
发表日期：2025
文献求助 收藏

The impact of tislelizumab immunotherapy on multiple primary lung cancer presenting as ground-glass nodules: preliminary results analysis from a single-arm, phase II trial.

替雷利珠单抗免疫疗法对表现为磨玻璃结节的多发性原发性肺癌的影响：一项单臂 II 期试验的初步结果分析。

期刊:Cancer Immunology Immunotherapy
影响因子:5.1
doi:10.1007/s00262-025-04212-y
Wu Junfei, Fu Xiangning, Gao Yi, Qin Shenghui, Xiong Jing, Qu Rirong, Cai Yixin
肺癌
免疫/内分泌
发表日期：2025
文献求助 收藏

Analysis of tumor cell proliferation (Ki-67) and cell cycle regulator proteins in lung adenocarcinoma with different radiological subtypes.

对不同放射学亚型肺腺癌中肿瘤细胞增殖（Ki-67）和细胞周期调节蛋白进行分析

期刊:Respiratory Research
影响因子:5
doi:10.1186/s12931-025-03217-6
Qu Rirong, Zhang Yang, Qin Shenghui, Xiong Jing, Fu Xiangning, Li Lequn, Tu Dehao, Cai Yixin
肿瘤
肺癌
Ki-67
发表日期：2025
文献求助 收藏

The correlation between EGFR mutation status and clinicopathological characteristics, Ki67 expression and immune cell infiltration in lung adenocarcinoma with different radiological subtypes.

EGFR 突变状态与肺腺癌不同放射学亚型的临床病理特征、Ki67 表达和免疫细胞浸润之间的相关性

期刊:World Journal of Surgical Oncology
影响因子:2.5
doi:10.1186/s12957-025-03960-6
Qu Rirong, Zhang Yang, Qin Shenghui, Xiong Jing, Fu Xiangning, Hu Shaojie, Cai Yixin
细胞生物学
肺癌
EGFR
发表日期：2025
文献求助 收藏

Successful conversion surgery following tislelizumab with chemotherapy in a patient with stage IIIC lung adenocarcinoma harboring RET fusions: A case report and review of the literature

一例携带RET融合基因的IIIC期肺腺癌患者，在接受替雷利珠单抗联合化疗后成功进行转化手术：病例报告及文献复习

期刊:
影响因子:
doi:10.3892/etm.2025.12820
Tu, De-Hao; Qu, Rirong; Wen, Fang; Zhou, Qiang; Liu, Qianyun; Huang, Lingmei; Chen, Tao
肿瘤
肿瘤免疫
RET
发表日期：2025
文献求助 收藏

Longitudinal changes in the volume of residual lung lobes after lobectomy for lung cancer: a retrospective cohort study

肺癌肺叶切除术后残余肺叶体积的纵向变化：一项回顾性队列研究

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-024-63013-y
Tu, De-Hao; Yi, Chong; Liu, Qianyun; Huang, Lingmei; Yang, Guang; Qu, Rirong
肺癌
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Distinct cellular immune profiles in lung adenocarcinoma manifesting as pure ground glass opacity versus solid nodules.

肺腺癌中纯磨玻璃影与实性结节表现出不同的细胞免疫特征

期刊:Journal of Cancer Research and Clinical Oncology
影响因子:2.8
doi:10.1007/s00432-022-04289-3
Qu Rirong, Ye Fan, Hu Shaojie, Wang Boyu, Qin Shenghui, Xiong Jing, Fu Xiangning, Li Lequn, Cai Yixin
细胞生物学
肺癌
肿瘤免疫
发表日期：2023
文献求助 收藏

Clinical Features and Surgical Treatment of Synchronous Multiple Primary Lung Adenocarcinomas With Different EGFR Mutations

具有不同EGFR突变的同步多原发性肺腺癌的临床特征和外科治疗

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2021.785777
Qu, Rirong; Ye, Fan; Tu, Dehao; Cai, Yixin; Fu, Xiangning
EGFR
肿瘤
EGF
肿瘤免疫
发表日期：2021
文献求助 收藏

Synchronous Multiple Lung Cancers with Lymph Node Metastasis and Different EGFR Mutations: Intrapulmonary Metastasis or Multiple Primary Lung Cancers?

同步多发性肺癌伴淋巴结转移及不同EGFR突变：是肺内转移还是多发性原发性肺癌？

期刊:Oncotargets and Therapy
影响因子:2.8
doi:10.2147/OTT.S294953
Qu, Rirong; Tu, Dehao; Ping, Wei; Zhang, Ni; Fu, Xiangning
肺癌
肿瘤
肿瘤免疫
EGF
EGFR
发表日期：2021
文献求助 收藏

The Impact of the Recurrent Laryngeal Nerve Injury on Prognosis After McKeown Esophagectomy for ESCC

喉返神经损伤对食管鳞状细胞癌McKeown食管切除术后预后的影响

期刊:Cancer Management and Research
影响因子:2.6
doi:10.2147/CMAR.S298228
Qu, Rirong; Tu, Dehao; Ping, Wei; Fu, Xiangning
肿瘤
肿瘤免疫
神经科学
神经损伤
细胞生物学
发表日期：2021
文献求助 收藏